‘First of its kind’ medication can significantly reduce heart attacks and strokes
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
Hosted on MSN1d
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
A mitochondrial protein's protective role offers new hope for Charcot-Marie-Tooth disease
Researchers from Cologne, Bochum, Padova and Angers have discovered a novel connection between mitochondrial function, ...
BioWorld3d
Parkin activation through PR-364 preserves cardiac function after acute MI in preclinical models
Heart disease remains the leading cause of death worldwide, and developing new therapeutic approaches constitutes an urgent healthcare priority. Almost one-third of patients surviving myocardial ...